Identifying people at risk of rheumatoid arthritis in primary care: a qualitative study
Open Access
- 17 January 2025
- journal article
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 75 (758) , e627-e636
Abstract
Background: Identification of rheumatoid arthritis (RA) in primary care is challenging and often delayed. Anticyclic citrullinated peptide (anti-CCP) antibody testing of people presenting to primary care with new-onset musculoskeletal symptoms without synovitis could help address this; those testing positive are at increased risk of developing RA. Aim: To explore how primary care clinicians currently identify and refer patients with suspected RA, and the behaviours required to implement a prediction model for guiding targeted anti-CCP testing for non-specific musculoskeletal symptoms in primary care. Design and setting: A qualitative descriptive study in primary care in England. Method: Eight GPs and eight musculoskeletal First Contact Practitioners (physiotherapists) participated in semi-structured interviews to explore their experiences of identifying and/or referring patients with suspected RA, and their views of a implementation package for the anti-CCP prediction model. Data were analysed using framework analysis. Results: Variations in practice were evident across the pathway for identifying and/or referring patients with suspected RA, including in access to and use of the anti-CCP test. Implementing the anti-CCP prediction model would require clinicians to believe its benefits outweigh its risks, engagement of primary and secondary care teams, and incorporation of the prediction model within an easily accessible and useable clinical-decision support system. Participants’ views about implementing the anti-CCP prediction model varied but were mostly positive overall. Conclusion: Implementing a prediction model to guide targeted anti-CCP testing in primary care could be feasible. Further research is required to explore the potential benefits, risks, and costs of a pathway for identifying and/or managing people at risk of RAKeywords
This publication has 39 references indexed in Scilit:
- A multivariable prediction model to identify anti-CCP positive people in those with non-specific musculoskeletal symptoms in primary careRheumatology, 2024
- Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trialThe Lancet, 2024
- Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trialThe Lancet, 2024
- Rheumatoid arthritisThe Lancet, 2023
- The experiences of uncertainty amongst musculoskeletal physiotherapists in first contact practitioner roles within primary careMusculoskeletal Care, 2023
- Facilitators and barriers in diagnosing rheumatoid arthritis as described by general practitioners: a Danish study based on focus group interviewsScandinavian Journal of Primary Health Care, 2021
- Primary care challenges in diagnosing and referring patients with suspected rheumatoid arthritis: a national cross-sectional GP surveyRheumatology Advances in Practice, 2018
- What do tests do for doctors? A qualitative study of blood testing in UK primary careFamily Practice, 2017
- Review: Preclinical Rheumatoid Arthritis: Progress Toward PreventionArthritis & Rheumatology, 2016
- The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: A systematic review and meta-analysisSeminars in Arthritis and Rheumatism, 2014